# Indapta Therapeutics Inc. — Form D

Indapta Therapeutics Inc. of Houston, TX, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-10. The offering totals $67.1M, of which $33.6M was reported sold. Industry: Other Technology.

## Offering

- Filed: 2022-02-10
- Form: D
- Accession: 0001910175-22-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $67.1M
- Amount sold: $33.6M
- Remaining: $33.5M
- Investors: 37
- Date of first sale: 2022-01-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-433098

## Issuer

- Name: Indapta Therapeutics Inc.
- CIK: 0001910175
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5000 Gulf Fwy. Building 4, Houston, TX, 77023
- Phone: 917-282-9768

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Laura Stoppel | Director | Sacramento, CA |
| Guy DiPierro | Executive Officer | Houston, TX |
| Lori Hu | Director | Houston, TX |
| Fabio Pucci | Director | Houston, TX |
| Ronald Martell | Director | Houston, TX |
| Mark Frohlich | Director | Houston, TX |
| Mark Frohlich | Executive Officer | Houston, TX |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-10-14](https://search.stillhousedata.com/formd/0001910175-25-000003) | D | $51.6M | $50.8M |

## More

- [CIK 1910175 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1910175&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001910175-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.